Literature DB >> 9020940

[Squamous cell carcinoma and basal cell carcinoma].

T Suzuki1, Y Inoue, A Kuramochi, Y Kiyohara, S Ikeda.   

Abstract

Both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are very common in skin malignancy. Operative therapy is the first choice at the treatment for SCC and BCC in early stage. After excision for large skin tumor, occasionally we use skin flap or musculocutaneous flap or free flap. At the old patient of Stage III and IV SCC and BCC, sometimes reduction surgery is useful at the combination therapy. Radiation as adjuvant therapy is sometimes useful for not only SCC but also BCC. The clinical efficacy of CA (C' A') chemotherapy (CDDP, ADM or CBDCA, EPI-ADM), was evaluated on Stage III, IV SCC and BCC. The response rate was 63% in SCC and 75% in BCC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020940

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma.

Authors:  Kenta Nakamura; Ryuhei Okuyama; Toshiaki Saida; Hisashi Uhara
Journal:  Int J Clin Oncol       Date:  2012-04-26       Impact factor: 3.402

2.  Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicin.

Authors:  Mayumi Okamoto; Takanobu Kan; Emi Murakami; Tomofumi Numata; Risa Otsuka; Manami Sueoka; Masaya Moriwaki; Shunsuke Takahagi; Akio Tanaka; Mikio Kawai; Hayato Mizuno; Michihiro Hide
Journal:  Eur J Hosp Pharm       Date:  2019-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.